Company Directory > Diagnostics > Svar Life Science
Svar Life Science (formerly Euro Diagnostica AB) is a specialized life science company that develops and applies analytical technologies across the drug development and clinical diagnostic value chain. The company is a global leader in the field of the complement system and autoimmunity, providing proprietary technology platforms like iLite® (cell-based reporter gene assays) and Wieslab® (ELISA-based complement assays). Headquartered in Malmö, Sweden, Svar serves pharmaceutical companies, CROs, and clinical laboratories by offering both off-the-shelf assay kits and custom bioanalytical services. Their solutions are critical for assessing drug potency, immunogenicity, and safety, particularly in the development of biologics and gene therapies.
CLASSIFICATION
Company Type:Diagnostics
Industry:Biotechnology
Sub-Industry:Diagnostics and Bioanalytical Services
SIZE & FINANCIALS
Employees:51-200
Revenue:$20M-$50M
Founded:1992
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Total Raised:$20M+
Investors:Adelis Equity Partners, Sunstone Life Science Ventures
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Assay Provider)
Modalities:Cell-based assays, ELISA, Reporter gene technology, LC-MS/MS
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Biomonitor (Acquired 2014)
Key Partnerships:Lablytica (Strategic partnership for LC-MS/MS services), Gyros Protein Technologies (Technology collaboration), Akero Therapeutics (Clinical trial support)
COMPETITION
Position:Niche Player
Competitors:Quanterix, Meso Scale Discovery (MSD), Eurofins, Charles River Laboratories, Olink Proteomics
LEADERSHIP
Key Executives:
Anne Thjømøe - CEO
Michael Schwenkert - Chief Product & Technology Officer
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Svar Life Science. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.